JPS62179380A - Apparatus for cell fusion - Google Patents

Apparatus for cell fusion

Info

Publication number
JPS62179380A
JPS62179380A JP2263486A JP2263486A JPS62179380A JP S62179380 A JPS62179380 A JP S62179380A JP 2263486 A JP2263486 A JP 2263486A JP 2263486 A JP2263486 A JP 2263486A JP S62179380 A JPS62179380 A JP S62179380A
Authority
JP
Japan
Prior art keywords
pipette
solution
tube
cell fusion
centrifugal tube
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2263486A
Other languages
Japanese (ja)
Inventor
Shinji Miyasaka
宮坂 信司
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Electric Industries Ltd
Original Assignee
Sumitomo Electric Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Electric Industries Ltd filed Critical Sumitomo Electric Industries Ltd
Priority to JP2263486A priority Critical patent/JPS62179380A/en
Publication of JPS62179380A publication Critical patent/JPS62179380A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/04Mechanical means, e.g. sonic waves, stretching forces, pressure or shear stimuli

Landscapes

  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • Mechanical Engineering (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

PURPOSE:To provide a cell fusion apparatus composed of a specific centrifugal tube holding tool, a centrifugal tube heating device, a pipette driving device, a liquid feed controlling device, a solution tube heating device and a controller and capable of realizing accurate and reproducible stirring, dilution, etc., in cell fusion process. CONSTITUTION:Solutions of two kinds of cells to be fused are mixed together in a centrifugal tube 1, which is treated with a centrifugal separator. After removing supernatant liquid, the centrifugal tube 1 is fixed to a holding tool 2. The solution is dripped from the solution tubes 5-7 into the centrifugal tube with a pipette 3 according to the procedure programmed by a controller 4 and the centrifugal tube is stirred by a pipette driving device. A centrifugal tube heating device 9 and a solution tube heating device 10 are furnished with a heat sensor and a heater. The pipette driving device is composed of a vertically driving means 81, a horizontally rotating means 82 and a radially driving means 83 and is operated according to the output of the controller 4.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は、細胞融合装置に関する。[Detailed description of the invention] [Industrial application field] The present invention relates to a cell fusion device.

[従来の技術] 細胞融合法は、モノクローナル抗体産生増殖細胞系等の
様に特徴のある増殖性雑種細胞系を新たに作製する手段
として、医薬、食品、農業等の各産業及び生物学、医学
、薬学の基礎研究において頻繁に用いられている。
[Prior Art] The cell fusion method is used in various industries such as medicine, food, agriculture, biology, medicine, etc. as a means to newly create a characteristic proliferative hybrid cell line such as a monoclonal antibody-producing proliferative cell line. , is frequently used in basic pharmaceutical research.

細胞融合法としては、ポリエチレングリコール(PEG
)、リゾレシチン、グリセロール、オレイン酸エステル
等の化学的細胞融合促進物質を用いる方法、不活性化し
たセンダイウィルス等の細胞融合促進力を持つウィルス
を用いる方法及び電気細胞融合法等が知られている。こ
の中で現在、最も頻繁に使用されている方法はPEGを
用いる方法である。この方法について、Ba1b/cマ
ウスの牌細胞とミエローマ細胞(例えばSp210−A
g+4)を用いた典型的な例について以下に説明する。
As a cell fusion method, polyethylene glycol (PEG)
), methods using chemical cell fusion-promoting substances such as lysolecithin, glycerol, and oleic acid esters, methods using inactivated viruses with cell fusion-promoting ability such as Sendai virus, and electric cell fusion methods are known. . Among these methods, the method most frequently used at present is the method using PEG. For this method, Ba1b/c mouse tile cells and myeloma cells (e.g. Sp210-A
A typical example using g+4) will be described below.

免疫したマウス(I3alb/c)数匹より牌臓を摘出
し、ハンクス成敗m(lを満たした100mmφンヤー
レ中にて、ピンセット等で11!臓細胞をしごき出す。
The spleens were removed from several immunized mice (I3alb/c), and the visceral cells were squeezed out using forceps or the like in a 100 mm diameter Nyare filled with a Hank's strainer.

牌細胞懸濁液を容jfi I 5 a(l程度の遠心デ
ユープに序し、遠心(1600rpm、  5分)した
後、上清を捨て、新たに溶血用溶液5〜7!!Qを加え
、ピペットにて@局し、約5分静置する。さらにハンク
ス液5〜7mQを加え、遠心し、上清を捨てる。これに
新たなハンクス成約10mQを加え、遠心上清を捨てる
。この操作を2回操り返し沈澱を適当量の培地又はハン
クス液に懸局させろ。血球算定板にて生細胞数をカウン
トし、+09([!itのマウス絆細胞を用伍する。ミ
エローマ細胞については、融合日の数日前より継代培養
を行なっていたものを上記と同様の遠心操作によってハ
ンクス液で2〜3回洗浄し、沈澱を適当量の培養液又は
ハンクス液に懸回し、血球算定板にて生細胞数をカウン
トし、10’gのミエローマ細胞を用意する。
Pour the tile cell suspension into a centrifugal duplex with a volume of about 5 liters, centrifuge (1600 rpm, 5 minutes), discard the supernatant, add a new hemolytic solution 5-7!!Q, Add 5 to 7 mQ of Hank's solution, centrifuge, and discard the supernatant. Add 10 mQ of Hank's solution and discard the centrifuged supernatant. Repeat this operation. Repeat the procedure twice and suspend the precipitate in an appropriate amount of medium or Hank's solution. Count the number of living cells using a hemocytometer and use mouse bond cells of +09 ([! The cells that have been subcultured for several days before the test were washed 2 to 3 times with Hank's solution by the same centrifugation procedure as above, and the precipitate was suspended in an appropriate amount of culture solution or Hank's solution, and the cells were collected using a hemocytometer plate. Count the number of living cells and prepare 10'g of myeloma cells.

用意した胛細胞2xl O”個、ミエローマ細胞5xi
 O’〜IxlOJlを容量501程度のプラスチック
遠心デユープ中で混和し、遠心(1600rpm。
Prepared 2xl O” cells, 5xi myeloma cells
O'~IxlOJl were mixed in a plastic centrifugal duplex with a capacity of about 50 ml, and centrifuged (1600 rpm).

5分)し、上清を捨てろ。37℃に保温しながらこの細
胞沈澱に50%PIEG(分子量1500〜4000程
度) I 5 mM HEP E S 、 D M E
溶液2mQをピペットにて撹拌しながら除々に(1分間
で217り加えてゆく。この後1分30秒の間ピペット
にて撹拌を行なった後、撹拌しながら初めの4分間で1
分毎に2Rρ次いで2分間でI2mQ、合計20J11
2のDMEを添加する。さらに、15mMHEPES、
DME溶液20!JQを加え、遠心(1600rpm、
5分)を行ない、上清を完全に取り除く。
5 minutes) and discard the supernatant. Add 50% PIEG (molecular weight approximately 1500 to 4000) I5mM HEPES, DME to this cell precipitate while keeping it warm at 37°C.
While stirring with a pipette, gradually add 2 mQ of the solution (in 1 minute).After this, stir with a pipette for 1 minute and 30 seconds, then add 1 mQ in the first 4 minutes while stirring.
2Rρ every minute then I2mQ for 2 minutes, total 20J11
Add 2 of DME. Furthermore, 15mM HEPES,
DME solution 20! Add JQ and centrifuge (1600 rpm,
5 minutes) and completely remove the supernatant.

沈澱状態のままで細胞に20%FCS、DME溶液約2
xQを重層し、約30分静置する。その後、20%FC
8,DME溶液を加えて、全量を40順とし、撹拌培養
用96穴プレ一ト2枚に、この溶液を各ウェル当たり2
00μgずつ分注し、培養を開始する。
Add 20% FCS and DME solution to the cells while still in the precipitated state.
Layer xQ and leave to stand for about 30 minutes. After that, 20%FC
8. Add DME solution to make the total volume 40 times, and add 2 portions of this solution per well to two 96-well plates for agitation culture.
Dispense 00 μg each and start culturing.

PEGを用いた細胞融合法の1例を説明したが、この一
連の操作の中で50%PEG分注からHEPES、DM
E溶液20mQ分注までの操作は、最適な方法が確立さ
れている訳でなく、溶液の分注量、分注速度、撹拌時間
および撹拌方法などは、融合に使用する細胞の種類、溶
液の種類および実験者などによって異なっている。これ
ら操作は、人手によって行なっているため、撹拌および
希釈などを常に正確にかつ再現性良〈実施することは、
非常に困難であり、また雑菌が系内に混入することがあ
った。
An example of a cell fusion method using PEG was explained, and in this series of operations, from dispensing 50% PEG to HEPES, DM
The optimal method for dispensing up to 20 mQ of E solution has not been established, and the amount of solution dispensed, dispensing speed, stirring time, stirring method, etc., depend on the type of cells used for fusion and the amount of solution. It varies depending on the type and experimenter. These operations are performed manually, so stirring and dilution are always accurate and reproducible.
It was very difficult to do so, and there were cases where bacteria were introduced into the system.

[発明の目的] 本発明は、こうした細胞融合時の撹拌および希釈などを
正確にかつ再現性良く実現し、雑菌の混入を防止し、さ
らに多様な条件に対応できる装置を提供することにある
[Object of the Invention] The object of the present invention is to provide an apparatus that can accurately and reproducibly perform such stirring and dilution during cell fusion, prevent contamination with various bacteria, and can respond to a variety of conditions.

[問題点を解決するための手段] 本発明の要旨は、遠心デユープ保持具、遠心チューブ保
温部、ピペット駆動部、送液制御部、溶液デユープ保温
部及びコントローラを有ずろ細胞融合装置であって、 (a)遠心チューブ保持具は遠心デユープの固定手段か
らなり、(b)遠心デユープ保温部および溶液デユープ
保温部は、デユープを保温する保温手段及びその温度を
測定する熱センサーを有し、(C)ピペット駆動部は、
ピペットとそのピペットを上下左右面後方向に駆動しう
る駆動手段からなり、(d)送液制御部は、ピペットへ
送液するポンプと、2種以上の溶液のピペットへの送液
を選択するバルブを有し、(e)コントローラは、予め
入力された作動条件に従ってピペット駆動部、送液制御
部、遠心チューブ保温部および溶液チューブ保温部を制
御することを特徴とする細胞融合装置に存する。
[Means for Solving the Problems] The gist of the present invention is a cell fusion device that includes a centrifugal duplex holder, a centrifugal tube warming section, a pipette drive section, a liquid feeding control section, a solution duplex warming section, and a controller. , (a) the centrifugal tube holder consists of means for fixing the centrifugal duplex; (b) the centrifugal duplex heat-retaining section and the solution duplex heat-insulating section have a heat-insulating means for keeping the duplex warm and a thermal sensor for measuring the temperature thereof; C) Pipette drive unit:
It consists of a pipette and a driving means capable of driving the pipette vertically, horizontally, and rearward, and (d) the liquid feeding control section selects a pump for feeding liquid to the pipette and liquid feeding of two or more types of solutions to the pipette. The cell fusion device has a valve, and (e) the controller controls a pipette drive section, a liquid feeding control section, a centrifuge tube warming section, and a solution tube warming section according to operating conditions input in advance.

実施例を示す図面に従って、本発明を以下に説明する。The invention will be explained below with reference to the drawings which show examples.

尚、本発明は以下の態様に限定されろものではない。Note that the present invention is not limited to the following embodiments.

第1図は、本発明の細胞融合装置の代表的な態様を示す
概略図である。融合しようとする2種の細胞溶液を遠心
チューブ(1)の中で混和し、遠心デユープ(1)を遠
心した後、上清を取り除き、遠心デユープ(1)を保持
具(2)に固定する。用いる遠心チューブ(1)は、細
胞処理用に市販されている、典型的なプラスチックコニ
カルデユープ(例えば、ファルコン社2070)などで
ある。保持具(2)は、典型的にはファルコン社207
0(直径30mm)を保持できるものであり、遠心チュ
ーブ保温部の保温効果が効率よく維持されるような位置
にデユープを保持する。
FIG. 1 is a schematic diagram showing a typical embodiment of the cell fusion device of the present invention. Mix the two types of cell solutions to be fused in a centrifuge tube (1), centrifuge the centrifuge duplex (1), remove the supernatant, and fix the centrifuge duplex (1) to the holder (2). . The centrifuge tube (1) used is a typical plastic conical tube (eg Falcon 2070) commercially available for cell processing. The retainer (2) is typically a Falcon 207
0 (30 mm in diameter), and the duplex is held at a position where the heat retaining effect of the centrifuge tube heat retaining part is efficiently maintained.

ピペット(3)は、コントローラ(4)でプログラムさ
れた手順により、溶液チューブ(586X7)からの溶
液を遠心チューブ内へ滴下しつつ、ピペット駆動部によ
って撹拌動作を行なう。典型的には、遠心チューブ(1
)内の液部分を1分間撹拌しながら、溶液デユープ(5
)の50%PEGを2mQ/分で1分間送液した後、送
液バルブの切換により溶液デユープ(6)のDMEを2
mQ1分で4分間、さらに6iQ/分で2分間送液する
。最後に溶液チューブ(7)からl 5mM HEPE
S、DME溶液を120酎/分で10秒間分注する。ピ
ペット(3)の撹拌方法および送液方法は、コントロー
ラ(4)内のメモリーにあらかじめ設定しておく。
The pipette (3) drips the solution from the solution tube (586×7) into the centrifuge tube according to the procedure programmed by the controller (4), and performs a stirring operation using the pipette drive unit. Typically, centrifuge tubes (1
) while stirring the liquid part in the solution duplex (5) for 1 minute.
) of 50% PEG was pumped at 2 mQ/min for 1 minute, and then the DME in the solution duplex (6) was pumped at 2 mQ/min by switching the liquid feeding valve.
The liquid is pumped for 4 minutes at mQ 1 minute and then for 2 minutes at 6 iQ/minute. Finally, add l 5mM HEPE from the solution tube (7).
S, DME solution is dispensed for 10 seconds at 120 ml/min. The stirring method and liquid feeding method of the pipette (3) are set in advance in the memory in the controller (4).

遠心チューブ保温部(9)および溶液チューブ保温部(
10)は、熱センサ−(例えば、熱電対)およびヒータ
ーを持し、これらを収容する容器にはブロックバス又は
恒温水槽を1■いる事がてきろ。
Centrifuge tube heat retention part (9) and solution tube heat retention part (
10) has a thermal sensor (for example, a thermocouple) and a heater, and the container housing them should include a block bath or a constant temperature water bath.

ピペット駆動部は、上下駆動部(81)、水平回転部(
82)および半径方向駆動部(83)から成り、コント
ローラー(4)の支持を受けてステソビノグモーター等
により動作し、遠心デユープ内でピペット先端をまんべ
んなく移動させ、結果としてピペットによる撹拌効果を
生じさせろ。ピペットの空間的駆動が実現できる駆動装
置であれば、どの様な方式を用いてもよい。
The pipette drive unit includes a vertical drive unit (81), a horizontal rotation unit (
82) and a radial drive unit (83), which is supported by a controller (4) and operated by a Stesobinog motor, etc., to move the pipette tip evenly within the centrifugal duplex, resulting in a stirring effect by the pipette. Let me. Any drive system may be used as long as it can realize spatial movement of the pipette.

コントローラ(4)は、ピペット(3)の駆動について
は駆動方向、駆動時間および駆動速度の制御を行う。溶
液チューブ(5X6 )(7)からの送液については液
の種類(バルブの選択)、送液速度および送液時間の制
御を行う。保温部(9)(10)については、熱センサ
ーからの電気信号より温度を計算し、ヒーターの0N1
0FF制御を行なってあらかじめ設定された温度(例え
ば、典型的には376C)を維持する。
The controller (4) controls the driving direction, driving time, and driving speed of the pipette (3). Regarding the liquid feeding from the solution tube (5×6) (7), the type of liquid (valve selection), liquid feeding speed, and liquid feeding time are controlled. Regarding the heat retaining parts (9) and (10), the temperature is calculated from the electrical signal from the heat sensor, and the temperature of the heater is 0N1.
0FF control is performed to maintain a preset temperature (eg, typically 376C).

送液制御部(11)は、送液のためのポンプ、例えばペ
リスタポンプと、液切換のためのバルブ、たとえば電磁
弁を有し、バルブの制御およびポンプの制御はコントロ
ーラ(4)により行われる。
The liquid feeding control unit (11) has a pump for liquid feeding, such as a peristaltic pump, and a valve for switching liquid, such as a solenoid valve, and the control of the valve and the pump is performed by the controller (4).

[発明の効果] 本発明の細胞融合装置の利点は以下のとおりである。[Effect of the invention] The advantages of the cell fusion device of the present invention are as follows.

(1)撹拌および希釈はコントローラの指示通り、正確
にかつ再現性良〈実施できるので、細胞融合時の最適な
融合条件が容易に決定でき、かつ再現性よく効果的な細
胞融合が行える。
(1) Stirring and dilution can be performed accurately and reproducibly according to the instructions of the controller, so the optimal fusion conditions for cell fusion can be easily determined, and effective cell fusion can be performed with high reproducibility.

(2)雑菌の混入を防止できろ。(2) Prevent contamination with germs.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は、本発明の細胞融合装置の代表的な態様を示す
概略図である。 l・・・遠心チューブ、2・・・遠心デユープ保持具、
3・・ピペット、4・・コントローラ、5.6.7・・
・溶液チューブ、81,82.83・・・ピペット駆動
部、9・・遠心チューブ保温部、IO・・・溶液チュー
ブ保温部、11・・・送液制御部。
FIG. 1 is a schematic diagram showing a typical embodiment of the cell fusion device of the present invention. l...Centrifugal tube, 2...Centrifugal duplex holder,
3. Pipette, 4. Controller, 5.6.7.
- Solution tube, 81, 82, 83... Pipette drive unit, 9... Centrifugal tube heat retention unit, IO... Solution tube heat retention unit, 11... Liquid feeding control unit.

Claims (1)

【特許請求の範囲】 1、遠心チューブ保持具、遠心チューブ保温部、ピペッ
ト駆動部、送液制御部、溶液チューブ保温部及びコント
ローラを有する細胞融合装置であって、 (a)遠心チューブ保持具は遠心チューブの固定手段か
らなり、(b)遠心チューブ保温部および溶液チューブ
保温部は、チューブを保温する保温手段及びその温度を
測定する熱センサーを有し、(c)ピペット駆動部は、
ピペットとそのピペットを上下左右前後方向に駆動しう
る駆動手段からなり、(d)送液制御部は、ピペットへ
送液するポンプと、2種以上の溶液のピペットへの送液
を選択するバルブを有し、(e)コントローラは、予め
入力された作動条件に従ってピペット駆動部、送液制御
部遠心チューブ保温部および溶液チューブ保温部を制御
することを特徴とする細胞融合装置。
[Scope of Claims] 1. A cell fusion device comprising a centrifuge tube holder, a centrifuge tube warming section, a pipette drive section, a liquid feeding control section, a solution tube warming section, and a controller, comprising: (a) a centrifuge tube holder; (b) The centrifuge tube heat retention unit and the solution tube heat retention unit include a heat retention unit that retains the temperature of the tube and a thermal sensor that measures the temperature thereof; (c) The pipette drive unit includes:
It consists of a pipette and a driving means that can drive the pipette in up, down, left, right, front and rear directions, and (d) the liquid feeding control section includes a pump that sends liquid to the pipette, and a valve that selects the feeding of two or more types of solutions to the pipette. (e) A cell fusion device characterized in that the controller controls a pipette driving section, a liquid feeding control section, a centrifugal tube warming section, and a solution tube warming section according to operating conditions inputted in advance.
JP2263486A 1986-02-03 1986-02-03 Apparatus for cell fusion Pending JPS62179380A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2263486A JPS62179380A (en) 1986-02-03 1986-02-03 Apparatus for cell fusion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2263486A JPS62179380A (en) 1986-02-03 1986-02-03 Apparatus for cell fusion

Publications (1)

Publication Number Publication Date
JPS62179380A true JPS62179380A (en) 1987-08-06

Family

ID=12088263

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2263486A Pending JPS62179380A (en) 1986-02-03 1986-02-03 Apparatus for cell fusion

Country Status (1)

Country Link
JP (1) JPS62179380A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5365798A (en) * 1992-05-15 1994-11-22 Behringwerke Aktiengesellschaft Pipetting device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5365798A (en) * 1992-05-15 1994-11-22 Behringwerke Aktiengesellschaft Pipetting device

Similar Documents

Publication Publication Date Title
AU2017357650B2 (en) Cell culture device system and methods of use thereof
US20220017850A1 (en) System, apparatus and method for the production of cells and/or cell products
US10435662B1 (en) Automated control of cell growth rates for induction and transformation
JP3630493B2 (en) Liquid processing method and apparatus using dispenser
JP6562552B2 (en) Synthesizer and synthesis method
CN106715674B (en) Apparatus, system and method for automated cell culture
CN104212704B (en) Microbiological culture media dispenser, microbiological culture media compound method and method for filling
US7910343B2 (en) Device and method for rapidly lysing cells or viruses
KR20150012778A (en) Automatic separation enrichment processing unit using magnetic nano particles
CN1229172C (en) Vessel for mixing cell lysate
CN117089458A (en) Device and method for automatic cell culture, gene editing, cell sorting and split charging
JPS62179380A (en) Apparatus for cell fusion
Charm et al. [37] Scale-Up of protein isolation
KR20220133257A (en) Electroporation modules and instruments
WO2012096559A1 (en) A cell culture tank
JPH0191771A (en) Cell proliferation apparatus
JP3793658B2 (en) Biological sample processing equipment
CN116134125A (en) Instant medical system for automated cell handling
CN115975794A (en) Device for automatic continuous circulating cell culture and treatment and operation method thereof
JPH0499477A (en) Extractor for nucleic acid
JPH0679166A (en) Apparatus for synthesis
JP2014161266A (en) Culture bag
CN217016634U (en) Coupling reaction device
RU119643U1 (en) HYDROLYSIS DEVICE
JPH03130067A (en) Device of immobilizing single stranded dna and immobilization